Dienogest Instructions

Instructions

Generic name: dienogest

Product name: Wei San Ning

All names: Dienogest, Visanne, Dienogest, Visanne

Indications: dienogest treatment of endometriosis.

Usage and dosage:

Dienogest is taken orally, one tablet a day without interruption, preferably at the same time every day, with water when necessary. Dienogest can be taken after a meal or on an empty stomach. The tablets must be taken continuously, regardless of whether vaginal bleeding occurs. If you finish taking one box, start taking the next box without interruption. You can start treatment with this product on any day of the menstrual cycle.

Adverse reactions:

The most common side effects of dienogest are headache, breast discomfort, including breast swelling, and breast pain. Adverse effects such as irregular bleeding are more common during the first few months of treatment with Visanin and gradually disappear as treatment continues.

Dienogest has no serious life-threatening side effects. Common side effects include amenorrhea, irregular bleeding, headache, chest discomfort, depression and acne, and can be recovered after stopping the medication.

Things to note:

Severe uterine bleeding: For example, in women with adenomyosis or uterine leiomyomas, uterine bleeding may worsen while taking dienogest tablets. If the bleeding is large or continuous, it may lead to anemia (severe anemia occurs in some cases). In the event of anemia, discontinuation of dienogest tablets should be considered.

Changes in Bleeding Patterns: Changes in menstrual bleeding patterns occurred in the majority of patients treated with dienogest tablets.

Circulatory disorders: Based on epidemiological studies, there is little evidence of an association between single progestin preparations and an increased risk of myocardial infarction or cerebral thromboembolism. However, the risk of cardiovascular and cerebrovascular events is significantly associated with increasing age, hypertension, and smoking. In women with high blood pressure, progestin-only medications may slightly increase the risk of stroke.

Some studies have shown that the risk of venous thromboembolism (deep vein thrombosis, pulmonary embolism) is slightly increased with the use of single progestin drugs, but the increase is not statistically significant. It is generally believed that risk factors for venous thromboembolism (VTE) include: a personal or family history of a sibling or parent who developed VTE at a relatively young age, age, obesity, long-term immobilization, major surgery, or severe trauma. In the case of long-term immobilization, it is best to stop using dienogest tablets (if elective surgery is to be performed, stop taking the medicine at least 4 weeks in advance), and resume use after 2 weeks of complete reactivation.

The increased risk of thromboembolism during the puerperium must be considered.

If symptoms of arterial or venous thrombosis are present or suspected, dienogest therapy should be discontinued immediately.

Cancer: A meta-analysis of 54 epidemiological studies reported that women currently using oral contraceptives (OCs) (mainly estrogen and progestin combinations) have a slightly increased relative risk of breast cancer.

The above is the content of the manual, I hope it can help you!

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.